WO2012131643A1 - Herbal compositions comprising pedilanthus tithymaloides for treatment prevention of gastrointestinal disorder - Google Patents

Herbal compositions comprising pedilanthus tithymaloides for treatment prevention of gastrointestinal disorder Download PDF

Info

Publication number
WO2012131643A1
WO2012131643A1 PCT/IB2012/051566 IB2012051566W WO2012131643A1 WO 2012131643 A1 WO2012131643 A1 WO 2012131643A1 IB 2012051566 W IB2012051566 W IB 2012051566W WO 2012131643 A1 WO2012131643 A1 WO 2012131643A1
Authority
WO
WIPO (PCT)
Prior art keywords
tithymaloides
pedilanthus
herbal compositions
herbal
compositions
Prior art date
Application number
PCT/IB2012/051566
Other languages
French (fr)
Inventor
Ananda Chandra RAULA
Original Assignee
Raula Ananda Chandra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raula Ananda Chandra filed Critical Raula Ananda Chandra
Publication of WO2012131643A1 publication Critical patent/WO2012131643A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/47Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

  • GI disorders gastrointestinal disorders
  • disorders or diseases related to the gastrointestinal tract which may be collectively referred to as gastrointestinal disorders (GI disorders)
  • GI disorders are common and often lead to severe pain and discomfort.
  • GI disorders including but not limited to constipation, gastrisis, fecal impaction, rectal prolapsed, gastrointestinal dysfunction, secretory diarrhea, gastroenteritis, GI bleeding, gastric and peptic ulcer, anorectal disorders, malabsorption syndromes, diverticular disease, tumors of GI tract, bezoars, dysentery, cholera, which have varied effects on the body or health of a subject.
  • the object of the invention is to provide novel herbal compositions which may be cost effective and easily available for treatment or prevention of gastrointestinal disorders, and which have less or no side effects to the health of a subject.
  • the present invention in a preferred embodiment provides herbal compositions for treatment or prevention of gastrointestinal disorders, comprising of at least a part of Pedilanthus tithymaloides, to which parts of one or more additional complimentary herb may be optionally added, wherein the additional complimentary herb is also a herb for treatment or prevention of gastrointestinal disorders and is selected from but not limited to Pergularia daemia, Sida acuta root, Phyllanthus reticulatus leaf, Ipomoea obscura leaf, Phoenix
  • the invention also provides for methods of preparation of the herbal compositions.
  • the present invention in a preferred embodiment provides herbal compositions for treatment or prevention of gastrointestinal disorders, comprising of at least a part of Pedilanthus tithymaloides, to which parts of one or more additional complimentary herb may be optionally added, wherein the additional complimentary herb is also a herb for treatment or prevention of gastrointestinal disorders and is selected from but not limited to Pergularia daemia, Sida acuta root, Phyllanthus reticulatus leaf, Ipomoea obscura leaf, Phoenix sylvestris, Ximenia americana, Semecarpus anacardium, Annona squamosa, common salt, or any combination thereof.
  • Parts of Pedilanthus tithymaloides for the purpose of this invention includes the whole Pedilanthus tithymaloides, extract of Pedilanthus tithymaloides, pulverized form of Pedilanthus tithymaloides, crushed form of Pedilanthus tithymaloides, pieces cut or severed from Pedilanthus tithymaloides, chemical constituents of Pedilanthus tithymaloides along with their derivatives, or any combination thereof.
  • the parts of Pedilanthus tithymaloides are severed by different methods such as but not limited to cutting, slicing, pounding, grinding, mashing or mincing.
  • composition' for the purpose of this invention means a substance or mixture comprising of at least one natural component having medicinal property, wherein the natural component shall include a component extracted or derived from a natural source such as a herb or a shrub or a tree or a plant or parts thereof.
  • the term subject for the purpose of the invention means one or more of a human or any other animal which has acquired or may acquire a disease or irregularity of health.
  • the herbs used for the compositions in accordance with the present invention shall include other herbs of their respective species or family or genus which display similar medicinal properties.
  • a solvent may be used for preparing the herbal compositions of the present invention, and the solvent used may be any suitable solvent such as but not limited to one or more of methanol, ethanol, n-propanol, isopropanol, hexane, heptane, petroleum ether, cyclohexane, diethyl ether, dusopropyl ether, ethyl acetate, methyl acetate, ethyl formate, methyl formate, isobutyl acetate, n-butyl acetate, methylene chloride, ethylene chloride, chloroform, carbon tetrachloride, acetone, ethyl methyl ketone, diisobutyl ketone, methyl isobutyl ketone, 1,4- dioxane, toluene, ammonia solution, glacial acetic acid, ammonium hydroxide, sodium hydroxide, calcium hydrox
  • a suitable excipient is added to the herbal compositions of the present invention to prepare a consumable formulation for effective therapeutic delivery.
  • the herbal compositions of the present invention may be formulated for oral administration by compounding the active ingredients with the usual nontoxic pharmaceutically acceptable excipients for tablets, pellets, granules, capsules, solutions, emulsions, suspensions, and any other form suitable for use.
  • Formulations in accordance with the present invention may include one or more of talc, water, glucose, lactose, gum acacia, gelatin, mannitol, starch paste, magnesium trisilicate, corn starch, keratin, colloidal silica, potato starch, urea, and other excipients suitable for use in manufacturing preparations, in solid, semisolid or liquid form, or any combination thereof.
  • auxiliary, stabilizing, thickening, flavoring, fragrance and coloring agents may be used.
  • the herbal compositions can be administered in a solid form such as but not limited to tablets, capsules, pills, pellets, granules, boluses or powder.
  • a solid form such as but not limited to tablets, capsules, pills, pellets, granules, boluses or powder.
  • the herbal compositions may be mixed with a pharmaceutical excipient such as but not limited to corn starch, lactose, sucrose, sorbitol, talc, stearic acid, magnesium stearate, dicalcium phosphate or gums, along with other pharmaceutical diluents.
  • the solid compositions may be further subdivided into unit dosage forms containing an effective amount of compositions of the present invention.
  • the herbal compositions can be administered in a liquid form such as but not limited to aqueous solution, suitably flavored syrups, aqueous suspensions, oil suspensions, tinctures, tisanes, macerates and flavored emulsions with edible oils as well as elixirs or similar pharmaceutical carriers.
  • the liquid form may include suitable dispersing or suspending agents for aqueous suspensions such as but not limited to tragacanth, acacia, alginate, dextran, sodium carboxymethyl cellulose, methylcellulose, polyvinylpyrrolidone or gelatin.
  • Liquid preparations for oral administration may take the form of, for example, solutions, syrups or suspensions, or they may be presented as a dry product for reconstitution with water or other suitable vehicles before use.
  • a process for preparing herbal compositions for treatment or prevention gastrointestinal disorders comprise the steps of,
  • a process for preparing herbal compositions for treatment or prevention gastrointestinal disorders comprise the steps of,
  • a process for preparing herbal compositions for treatment or prevention gastrointestinal disorders comprise the steps of,
  • the herbal compositions may be delivered as a semi-solid form or gelatinous solid, such as but not limited to paste, jelly, gel or chutney.
  • the herbal compositions may be delivered as a gaseous form or in form of aerosols which includes but not limited to spray, fumes, inhalers or mist.
  • the herbal compositions may also be formulated for parenteral administration by injection, which includes but is not limited to, using conventional catheterization techniques or infusion.
  • the herbal compositions may also be formulated for topical administration, in the form of solution, cream, gel, ointment, powder, paste, gum or lozenge, using techniques known to those skilled in the formulation field.
  • topical administration includes delivery of the compositions to mucosal tissue of the mouth, nose and throat by, for example, spray or mist application.
  • the herbal compositions as an active ingredient may be used alone or in combination with other therapeutic agents, for treatment or prevention of gastrointestinal disorders.
  • the herbal compositions of the present invention may be in the form of a decoction or may be prepared using a decoction process.
  • the parts of Pedilanthus tithymaloides can be given chemical treatment or made to react with other chemical reagents to form mixtures or herbal compositions which are used for treatment or prevention of gastrointestinal disorders.
  • the desirable dose of the compositions may vary depending on the condition and the weight of the subject, severity, drug form, route and period of administration.
  • a gastrointestinal disorder is selected from a set of but not limited to gastrointestinal dysfunction, diarrhea, gastroenteritis, GI bleeding, gastric and peptic ulcer, anorectal disorders, gastric hyperacidity, hypochlorhydria, malabsorption syndromes, diverticular disease, tumors of GI tract, bezoars, dysentery, cholera, flatulence, or any combination thereof.
  • the herbal composition may be used for treatment or prevention of a gastrointestinal disorders that may be caused by one or more of cestodes, nematodes and trematodes, such as but not limited to roundworms, tapeworms, ringworms, pinworm, hookworm, Filariasis, Onchocerciasis, Schistosomiasis, Trichinella and Guinea Worm, or any combination thereof.
  • cestodes such as but not limited to roundworms, tapeworms, ringworms, pinworm, hookworm, Filariasis, Onchocerciasis, Schistosomiasis, Trichinella and Guinea Worm, or any combination thereof.
  • the herbal composition may be used for treatment or prevention of a gastrointestinal disorders that may be caused by one or more of Protozoa, Spironucleus muris, Giardia muris, Tritrichomonas muris, Entamoeba muris, Helminths, Syphacia muris, Aspicularis tetraptera, Trichosomoides crassicauda, Strongyloides ratti, Nippostrongylus muris, Hymenolepis nana, Hymenolepis diminuta, Taenia taeniaeformis, Taenia seralis, Acanthocephala, Moniliformis moniliformis, Vibrio cholerae, or any combination thereof.
  • Protozoa Spironucleus muris, Giardia muris, Tritrichomonas muris, Entamoeba muris, Helminths, Syphacia muris, Aspicularis tetraptera, Trichosomoides crass

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention in a preferred embodiment provides for herbal compositions for treatment or prevention of gastrointestinal disorders. The present invention also provides for the methods of preparation and various forms of administration of the said compositions. The said compositions comprise of at least a part of Pedilanthus tithymaloides.

Description

HERBAL COMPOSITIONS COMPRISING PEDILANTHUS TITHYMALOIDES FOR TREATMENT OR PREVENTION OF GASTROINTESTINAL DISORDER
BACKGROUND:
Disorders or diseases related to the gastrointestinal tract which may be collectively referred to as gastrointestinal disorders (GI disorders), are common and often lead to severe pain and discomfort. There are various kinds of GI disorders including but not limited to constipation, gastrisis, fecal impaction, rectal prolapsed, gastrointestinal dysfunction, secretory diarrhea, gastroenteritis, GI bleeding, gastric and peptic ulcer, anorectal disorders, malabsorption syndromes, diverticular disease, tumors of GI tract, bezoars, dysentery, cholera, which have varied effects on the body or health of a subject.
Although, there are synthetic medicines and associated treatment methods available for addressing, gastrointestinal disorders, most of them pose the threat of side effects and chemical toxicity which can adversely affect a subject's overall health, and mostly involve high cost and effort in manufacturing.
Considering the significance of gastrointestinal disorders, there is a continuous requirement for medicines or compositions for their treatment, which would be economical, easily available and may have lower side effects and lower toxicities affecting a subject's body, which can be addressed by herbal compositions of the present invention.
OBJECT OF THE INVENTION:
The object of the invention is to provide novel herbal compositions which may be cost effective and easily available for treatment or prevention of gastrointestinal disorders, and which have less or no side effects to the health of a subject.
SUMMARY OF THE INVENTION:
The present invention in a preferred embodiment provides herbal compositions for treatment or prevention of gastrointestinal disorders, comprising of at least a part of Pedilanthus tithymaloides, to which parts of one or more additional complimentary herb may be optionally added, wherein the additional complimentary herb is also a herb for treatment or prevention of gastrointestinal disorders and is selected from but not limited to Pergularia daemia, Sida acuta root, Phyllanthus reticulatus leaf, Ipomoea obscura leaf, Phoenix
l sylvestris, Ximenia americana, Semecarpus anacardium, Annona squamosa, common salt, or any combination thereof. The invention also provides for methods of preparation of the herbal compositions.
DETAIL DESCRITION OF THE INVENTION:
The present invention in a preferred embodiment provides herbal compositions for treatment or prevention of gastrointestinal disorders, comprising of at least a part of Pedilanthus tithymaloides, to which parts of one or more additional complimentary herb may be optionally added, wherein the additional complimentary herb is also a herb for treatment or prevention of gastrointestinal disorders and is selected from but not limited to Pergularia daemia, Sida acuta root, Phyllanthus reticulatus leaf, Ipomoea obscura leaf, Phoenix sylvestris, Ximenia americana, Semecarpus anacardium, Annona squamosa, common salt, or any combination thereof.
Parts of Pedilanthus tithymaloides for the purpose of this invention includes the whole Pedilanthus tithymaloides, extract of Pedilanthus tithymaloides, pulverized form of Pedilanthus tithymaloides, crushed form of Pedilanthus tithymaloides, pieces cut or severed from Pedilanthus tithymaloides, chemical constituents of Pedilanthus tithymaloides along with their derivatives, or any combination thereof.
In an embodiment of the invention, the parts of Pedilanthus tithymaloides are severed by different methods such as but not limited to cutting, slicing, pounding, grinding, mashing or mincing.
The term 'herbal composition' for the purpose of this invention means a substance or mixture comprising of at least one natural component having medicinal property, wherein the natural component shall include a component extracted or derived from a natural source such as a herb or a shrub or a tree or a plant or parts thereof.
The term subject for the purpose of the invention means one or more of a human or any other animal which has acquired or may acquire a disease or irregularity of health. The herbs used for the compositions in accordance with the present invention, shall include other herbs of their respective species or family or genus which display similar medicinal properties.
In an embodiment of the invention, a solvent may be used for preparing the herbal compositions of the present invention, and the solvent used may be any suitable solvent such as but not limited to one or more of methanol, ethanol, n-propanol, isopropanol, hexane, heptane, petroleum ether, cyclohexane, diethyl ether, dusopropyl ether, ethyl acetate, methyl acetate, ethyl formate, methyl formate, isobutyl acetate, n-butyl acetate, methylene chloride, ethylene chloride, chloroform, carbon tetrachloride, acetone, ethyl methyl ketone, diisobutyl ketone, methyl isobutyl ketone, 1,4- dioxane, toluene, ammonia solution, glacial acetic acid, ammonium hydroxide, sodium hydroxide, calcium hydroxide, calcium carbonate, potassium hydroxide, potassium carbonate, water and other solvents known by those of skilled in the art.
In an embodiment of the invention, a suitable excipient is added to the herbal compositions of the present invention to prepare a consumable formulation for effective therapeutic delivery.
In an embodiment of the invention, the herbal compositions of the present invention may be formulated for oral administration by compounding the active ingredients with the usual nontoxic pharmaceutically acceptable excipients for tablets, pellets, granules, capsules, solutions, emulsions, suspensions, and any other form suitable for use. Formulations in accordance with the present invention may include one or more of talc, water, glucose, lactose, gum acacia, gelatin, mannitol, starch paste, magnesium trisilicate, corn starch, keratin, colloidal silica, potato starch, urea, and other excipients suitable for use in manufacturing preparations, in solid, semisolid or liquid form, or any combination thereof. Additionally, auxiliary, stabilizing, thickening, flavoring, fragrance and coloring agents may be used.
In an embodiment of the invention, the herbal compositions can be administered in a solid form such as but not limited to tablets, capsules, pills, pellets, granules, boluses or powder. For preparing the solid form, the herbal compositions may be mixed with a pharmaceutical excipient such as but not limited to corn starch, lactose, sucrose, sorbitol, talc, stearic acid, magnesium stearate, dicalcium phosphate or gums, along with other pharmaceutical diluents. The solid compositions may be further subdivided into unit dosage forms containing an effective amount of compositions of the present invention.
In an embodiment of the invention, the herbal compositions can be administered in a liquid form such as but not limited to aqueous solution, suitably flavored syrups, aqueous suspensions, oil suspensions, tinctures, tisanes, macerates and flavored emulsions with edible oils as well as elixirs or similar pharmaceutical carriers. The liquid form may include suitable dispersing or suspending agents for aqueous suspensions such as but not limited to tragacanth, acacia, alginate, dextran, sodium carboxymethyl cellulose, methylcellulose, polyvinylpyrrolidone or gelatin. Liquid preparations for oral administration may take the form of, for example, solutions, syrups or suspensions, or they may be presented as a dry product for reconstitution with water or other suitable vehicles before use.
In an embodiment of the invention, a process for preparing herbal compositions for treatment or prevention gastrointestinal disorders, comprise the steps of,
a) washing a part of Pedilanthus tithymaloides;
b) sieving the part of Pedilanthus tithymaloides; and
c) preparing pharmaceutically acceptable formulation thereof.
In an embodiment of the invention, a process for preparing herbal compositions for treatment or prevention gastrointestinal disorders, comprise the steps of,
a) washing a part of Pedilanthus tithymaloides and a part of an additional herb; b) sieving the part of Pedilanthus tithymaloides and the part of an additional herb;
c) mixing the part of Pedilanthus tithymaloides and the part of an additional herb; and
d) preparing pharmaceutically acceptable formulation thereof.
In an embodiment of the invention, a process for preparing herbal compositions for treatment or prevention gastrointestinal disorders, comprise the steps of,
a) washing a part of Pedilanthus tithymaloides, a part of Pergularia daemia, a part of Sida acuta root, a part of Phyllanthus reticulatus leaf, a part of Ipomoea obscura leaf, a part of Phoenix sylvestris, a part of Ximenia americana, a part of Semecarpus anacardium, and a part of Annona squamosa; b) sieving the part of Pedilanthus tithymaloides, the part of Pergularia daemia, the part of Sida acuta root, the part of Phyllanthus reticulatus leaf, the part of Ipomoea obscura leaf, the part of Phoenix sylvestris, the part of Ximenia americana, the part of Semecarpus anacardium, and the part of Annona squamosa;
c) mixing the part of Pedilanthus tithymaloides, the part of Pergularia daemia, the part of Sida acuta root, the part of Phyllanthus reticulatus leaf, the part of Ipomoea obscura leaf, the part of Phoenix sylvestris, the part of Ximenia americana, the part of Semecarpus anacardium, and the part of Annona squamosa;
d) heating the above mixture in a vessel containing a solvent; and
e) preparing pharmaceutically acceptable formulation thereof.
In an embodiment of the invention, the herbal compositions may be delivered as a semi-solid form or gelatinous solid, such as but not limited to paste, jelly, gel or chutney.
In an embodiment of the invention, the herbal compositions may be delivered as a gaseous form or in form of aerosols which includes but not limited to spray, fumes, inhalers or mist.
In an embodiment of the invention, the herbal compositions may also be formulated for parenteral administration by injection, which includes but is not limited to, using conventional catheterization techniques or infusion.
In an embodiment of the invention, the herbal compositions may also be formulated for topical administration, in the form of solution, cream, gel, ointment, powder, paste, gum or lozenge, using techniques known to those skilled in the formulation field. As used herein, topical administration includes delivery of the compositions to mucosal tissue of the mouth, nose and throat by, for example, spray or mist application.
In an embodiment of the invention, the herbal compositions as an active ingredient may be used alone or in combination with other therapeutic agents, for treatment or prevention of gastrointestinal disorders. In an embodiment of the invention, the herbal compositions of the present invention may be in the form of a decoction or may be prepared using a decoction process.
In an embodiment of the invention, the parts of Pedilanthus tithymaloides can be given chemical treatment or made to react with other chemical reagents to form mixtures or herbal compositions which are used for treatment or prevention of gastrointestinal disorders.
In an embodiment of the invention, the desirable dose of the compositions may vary depending on the condition and the weight of the subject, severity, drug form, route and period of administration.
In an embodiment of the invention, a gastrointestinal disorder is selected from a set of but not limited to gastrointestinal dysfunction, diarrhea, gastroenteritis, GI bleeding, gastric and peptic ulcer, anorectal disorders, gastric hyperacidity, hypochlorhydria, malabsorption syndromes, diverticular disease, tumors of GI tract, bezoars, dysentery, cholera, flatulence, or any combination thereof.
In an embodiment of the invention, the herbal composition may be used for treatment or prevention of a gastrointestinal disorders that may be caused by one or more of cestodes, nematodes and trematodes, such as but not limited to roundworms, tapeworms, ringworms, pinworm, hookworm, Filariasis, Onchocerciasis, Schistosomiasis, Trichinella and Guinea Worm, or any combination thereof.
In an embodiment of the invention, the herbal composition may be used for treatment or prevention of a gastrointestinal disorders that may be caused by one or more of Protozoa, Spironucleus muris, Giardia muris, Tritrichomonas muris, Entamoeba muris, Helminths, Syphacia muris, Aspicularis tetraptera, Trichosomoides crassicauda, Strongyloides ratti, Nippostrongylus muris, Hymenolepis nana, Hymenolepis diminuta, Taenia taeniaeformis, Taenia seralis, Acanthocephala, Moniliformis moniliformis, Vibrio cholerae, or any combination thereof.
It is observed that when more than one herbs are used in the herbal compositions of the present invention, there is enhanced efficacy and the combination of herbs lead to synergistic effect. The aim of this specification is to describe the invention without limiting the invention to any one embodiment or specific collection of features. A person skilled in the relevant art may realize the variations from the specific embodiments that will nonetheless fall within the scope of the invention, and such variations are deemed to be within the scope of the current invention.
It may be appreciated that various other modifications and changes may be made to the embodiment described without departing from the spirit and scope of the invention.
Example 1:
lOOgm of leaves of Pedilanthus tithymaloides was mixed with 50gms of common salt and were subject to grinding together to make a paste. This paste was given to the subject suffering from stomach pain due to gastrointestinal disorder to eat after which the intensity of pain reduced considerably and the subject was in better medical condition.

Claims

I CLAIM:
1) Herbal compositions for treatment or prevention of gastrointestinal disorders, the herbal compositions comprising at least a part of Pedilanthus tithymaloides .
2) Herbal compositions as claimed in claim 1, wherein said herbal compositions is selected from a group comprising whole Pedilanthus tithymaloides, extracts of Pedilanthus tithymaloides, crushed Pedilanthus tithymaloides, pulverized Pedilanthus tithymaloides, severed Pedilanthus tithymaloides, chemical constituents of Pedilanthus tithymaloides, and any combination thereof.
3) Herbal compositions as claimed in any of the preceding claims, wherein said herbal compositions further comprise additional herbs.
4) Herbal compositions as claimed in any of the preceding claims, wherein said herbal compositions further comprise additional herbs selected from Pergularia daemia, Sida acuta root, Phyllanthus reticulatus leaf, Ipomoea obscura leaf, Phoenix sylvestris, Ximenia americana, Semecarpus anacardium, Annona squamosa, common salt, or any combination thereof.
5) Herbal compositions as claimed in any of the preceding claims, wherein the herbal compositions of the invention further comprises one or more of solvents, excipients, auxiliary agents, stabilizing agents, thickening agents, flavoring agents, fragrance, preservatives, fillers, coloring agents, and any combination thereof.
6) Herbal compositions as claimed in any of the preceding claims, wherein the herbal compositions of the invention treats or prevents gastrointestinal disorders selected from gastrointestinal dysfunction, diarrhea, gastroenteritis, GI bleeding, gastric and peptic ulcer, anorectal disorders, gastric hyperacidity, hypochlorhydria, malabsorption syndromes, diverticular disease, tumors of GI tract, bezoars, dysentery, cholera, flatulence, and any combination thereof.
7) An herbal composition as claimed in any of the preceding claims, wherein the herbal composition of the invention treats or prevents endoparasites selected from cestodes, nematodes, trematodes, roundworms, tapeworms, ringworms, pinworm, hookworm, Filariasis, Onchocerciasis, Schistosomiasis, Trichinella, Guinea Worm, Spironucleus muris, Giardia muris, Tritrichomonas muris, Entamoeba muris, Helminths, Nematodes, Syphacia muris, Aspicularis tetraptera, Trichosomoides crassicauda, Strongyloides ratti, Nippostrongylus muris, Cestodes, Hymenolepis nana, Hymenolepis diminuta, Taenia taeniaeformis, Taenia seralis, Acanthocephala, Moniliformis moniliformis, and any combination thereof.
8) Herbal compositions as claimed in any of the preceding claims, wherein the herbal compositions is in forms selected from a group comprising of injectable forms; solid tablets, pellets, granules, capsules, forms; oral usage form; topical application form; semi-solid form; gaseous form; and any combination thereof.
9) A process for preparing herbal compositions for treatment or prevention gastrointestinal disorders, comprise the steps of,
a) washing a part of Pedilanthus tithymaloides;
b) sieving the part of Pedilanthus tithymaloides; and
c) preparing pharmaceutically acceptable formulation thereof.
10) A process for preparing herbal compositions as claimed in any of the preceding claims, comprise the steps of,
a) washing a part of Pedilanthus tithymaloides and a part of an additional herb; b) sieving the part of Pedilanthus tithymaloides and the part of an additional herb;
c) mixing the part of Pedilanthus tithymaloides and the part of an additional herb; and
d) preparing pharmaceutically acceptable formulation thereof.
PCT/IB2012/051566 2011-04-01 2012-03-30 Herbal compositions comprising pedilanthus tithymaloides for treatment prevention of gastrointestinal disorder WO2012131643A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN462KO2011 2011-04-01
IN462/KOL/2011 2011-04-01

Publications (1)

Publication Number Publication Date
WO2012131643A1 true WO2012131643A1 (en) 2012-10-04

Family

ID=46178580

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2012/051566 WO2012131643A1 (en) 2011-04-01 2012-03-30 Herbal compositions comprising pedilanthus tithymaloides for treatment prevention of gastrointestinal disorder

Country Status (1)

Country Link
WO (1) WO2012131643A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104013700A (en) * 2014-06-26 2014-09-03 重庆市畜牧科学院 Traditional Chinese medicine composition for treating damp-heat type yellow and white scour of piglets as well as preparation and preparation method thereof
CN104189167A (en) * 2014-09-10 2014-12-10 河南亚卫动物药业有限公司 Cataplasm for treating piglet diarrhea and preparation method of cataplasm
CN107115433A (en) * 2017-03-29 2017-09-01 三穗县妇幼保健计划生育服务中心 A kind of bowel lavage Chinese medicine preparation for treating Children's diarrhea vein

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ABREU P ET AL: "Anti-inflammatory and antioxidant activity of a medicinal tincture from Pedilanthus tithymaloides", LIFE SCIENCES, vol. 78, no. 14, 28 February 2006 (2006-02-28), PERGAMON PRESS, OXFORD, GB, pages 1578 - 1585, XP028050571, ISSN: 0024-3205, [retrieved on 20060228], DOI: 10.1016/J.LFS.2005.07.037 *
ADZU B. ET AL.: "Assessing the potency of Pedilanthus tithymaloides latex against Plasmodium berghei berghei infected mice.", 2008, XP002679095, Retrieved from the Internet <URL:http://www.ajol.info/index.php/ijbcs/article/view/39742> [retrieved on 20120703] *
MONGKOLVISUT W ET AL: "Antimalarial and antituberculous poly-O-acylated jatrophane diterpenoids from Pedilanthus tithymaloides", JOURNAL OF NATURAL PRODUCTS, vol. 70, no. 9, September 2007 (2007-09-01), US, pages 1434 - 1438, XP002679094, ISSN: 0163-3864, DOI: 10.1021/NP070174V *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104013700A (en) * 2014-06-26 2014-09-03 重庆市畜牧科学院 Traditional Chinese medicine composition for treating damp-heat type yellow and white scour of piglets as well as preparation and preparation method thereof
CN104189167A (en) * 2014-09-10 2014-12-10 河南亚卫动物药业有限公司 Cataplasm for treating piglet diarrhea and preparation method of cataplasm
CN107115433A (en) * 2017-03-29 2017-09-01 三穗县妇幼保健计划生育服务中心 A kind of bowel lavage Chinese medicine preparation for treating Children's diarrhea vein

Similar Documents

Publication Publication Date Title
CN1853682A (en) Plant based dietary supplement for improving the duration and quality of sleep
CN101031298B (en) Medicine with analgesic function
CN110151823A (en) A kind of application of cinnamon essential oil
WO2012131643A1 (en) Herbal compositions comprising pedilanthus tithymaloides for treatment prevention of gastrointestinal disorder
KR101346066B1 (en) Pharmaceutical composition containing Yellow-popular bark extract as active ingredient
CN109350670A (en) The preparation method of Ynxingchao dropping pills compound
CN100473388C (en) Extraction of effective portion of gryllotalpidae for anti-cancers and preparation thereof
CN108938864A (en) A kind of application of Chinese medicine composition in the drug of preparation treatment herpesvirus infection associated diseases
US20130136811A1 (en) Compositions and Methods for Pain Reduction
JP2018188377A (en) Pharmaceutical composition
Das et al. Antinociceptive, anti-inflammatory and hypoglycemic activities of Terminalia citrina leaves
KR100522176B1 (en) Composition for improving male sexual function
WO2012131641A1 (en) Herbal compositions comprising vernonia cinerea with anti - bacterial anti - endoparasitic properties
JP4950551B2 (en) Gastrointestinal mucosa protective agent
WO2012131650A1 (en) Herbal compositions of coccinia indica for treatment or prevention of inflammatory diseases
CN1968694B (en) An analgesic pharmaceutical composition
WO2012131652A1 (en) Herbal compositions for treatment or prevention of neurological disorders
CN109248165A (en) A kind of application with the compound for improving immunity and its in preparation raising immunity drug
CN110123982A (en) A kind of application of tsaoko essential oil
CN103893512B (en) A kind of Chinese medicine composition for treating urarthritis
WO2022119352A1 (en) Antitussive and mucoactive composition comprising extract of hibiscus syriacus l. as active ingredient
CN113181205B (en) Pharmaceutical composition comprising NMN and use thereof
WO2012131649A1 (en) Herbal compositions comprising coldenia procumbens for treatment or prevention of udder sore
KR20150048366A (en) Liver cytoprotective composition comprising an extract of brassica juncea coss. and compounds isolated therefrom
JP4547892B2 (en) α-Glucosidase inhibitor

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12724390

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12724390

Country of ref document: EP

Kind code of ref document: A1